Cas:1228566-94-6 (S)-tert-butyl 6-oxopiperidin-3-ylcarbamate manufacturer & supplier

Chemical Name:(S)-tert-butyl 6-oxopiperidin-3-ylcarbamate

CAS.NO:1228566-94-6

Synonyms:(S)-tert-butyl 6-oxopiperidin-3-ylcarbamate

Molecular Formula:C₁₀H₁₈N₂O₃

Molecular Weight:214.26152

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:

Exact Mass:

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like (S)-tert-butyl 6-oxopiperidin-3-ylcarbamate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(S)-tert-butyl 6-oxopiperidin-3-ylcarbamate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(S)-tert-butyl 6-oxopiperidin-3-ylcarbamate Use and application,(S)-tert-butyl 6-oxopiperidin-3-ylcarbamate technical grade,usp/ep/jp grade.

Related News: Onconova has conducted trials with two other research compounds and has a pre-clinical program with a CDK4/6 and Ark5 inhibitor, ON 123300. (S)-tert-butyl 6-oxopiperidin-3-ylcarbamate manufacturer The firm announced its own acquisition of California-based chemical, manufacturing and control (CMC) advisor Chamow & Associates back in January to bolster Alira’s biologics manufacturing, quality assurance and regulatory compliance business. Further yet, 12 months ago, Alira picked up French consulting firm Care Factory for its data science experts and electronic health record database knowledge. (S)-tert-butyl 6-oxopiperidin-3-ylcarbamate supplier Bristol-Myers Squibb (BMS) recently acquired Celgene, for example, which had the highest proportional R&D spend. (S)-tert-butyl 6-oxopiperidin-3-ylcarbamate vendor By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant��s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed. (S)-tert-butyl 6-oxopiperidin-3-ylcarbamate factory By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant��s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed.